Author

C Peralta Viteri

University of Würzburg

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1

Frequent Co-Authors

Kai KretzschmariD· 1 shared Lili Szabó· 1 shared Nadja Harnischfeger· 1 shared Stefan Hartmann· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

4 top collaborators · 6 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Kai KretzschmarORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

NELLY enables patient-centric drug prioritization through interpretable drug-conditioned gene weighting

C Peralta Viteri, Nadja Harnischfeger, Lili Szabó, Stefan Hartmann, Kai Kretzschmar

This paper introduces NELLY, a deep learning model that prioritizes patient-specific therapies by integrating transcriptomic and chemical data, outperforming existing methods in drug response prediction.

bioRxiv · Aug 26, 2026 · PreprintCancer Biology